GB201006846D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201006846D0
GB201006846D0 GBGB1006846.8A GB201006846A GB201006846D0 GB 201006846 D0 GB201006846 D0 GB 201006846D0 GB 201006846 A GB201006846 A GB 201006846A GB 201006846 D0 GB201006846 D0 GB 201006846D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1006846.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COVERGENCE PHARMACEUTICALS LIMITED
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB1006846.8A priority Critical patent/GB201006846D0/en
Publication of GB201006846D0 publication Critical patent/GB201006846D0/en
Priority to PCT/GB2011/050767 priority patent/WO2011131975A1/fr
Priority to JP2013505542A priority patent/JP2013525339A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB1006846.8A 2010-04-23 2010-04-23 Novel compounds Ceased GB201006846D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1006846.8A GB201006846D0 (en) 2010-04-23 2010-04-23 Novel compounds
PCT/GB2011/050767 WO2011131975A1 (fr) 2010-04-23 2011-04-19 Inhibiteurs microsomaux de la prostaglandine e synthase-1
JP2013505542A JP2013525339A (ja) 2010-04-23 2011-04-19 ミクロソームプロスタグランジンｅ合成酵素−１阻害剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1006846.8A GB201006846D0 (en) 2010-04-23 2010-04-23 Novel compounds

Publications (1)

Publication Number Publication Date
GB201006846D0 true GB201006846D0 (en) 2010-06-09

Family

ID=42270760

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1006846.8A Ceased GB201006846D0 (en) 2010-04-23 2010-04-23 Novel compounds

Country Status (3)

Country Link
JP (1) JP2013525339A (fr)
GB (1) GB201006846D0 (fr)
WO (1) WO2011131975A1 (fr)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193011A (en) 1979-03-19 1983-03-15 Ici Australia Ltd Diarylamine derivatives intermediates herbicidal compositions
WO2005005415A1 (fr) 2003-07-09 2005-01-20 Biolipox Ab Indoles utilises dans le traitement de l'inflammation
CN101006054A (zh) 2004-06-18 2007-07-25 比奥里波克斯公司 用于炎症治疗的吲哚
US7442716B2 (en) 2004-12-17 2008-10-28 Merck Frosst Canada Ltd. 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
ES2410905T3 (es) 2004-12-17 2013-07-03 Merck Canada Inc. 2-(Fenil o heterociclo)-1H-fenantro[9,10-d]imidazoles como inhibidores de la MPGES-1
US20090069384A1 (en) 2005-01-19 2009-03-12 Biolipox Ab Thienopyrroles useful in the treatment of inflammation
WO2006077367A1 (fr) 2005-01-19 2006-07-27 Biolipox Ab Indoles utiles dans le traitement de l'inflammation
WO2006077401A1 (fr) 2005-01-19 2006-07-27 Biolipox Ab Pyrrolopyridines utiles dans le traitement de l'inflammation
ZA200705827B (en) 2005-01-19 2008-10-29 Biolipox Ab Indoles useful in the treatment of inflammation
WO2006077364A1 (fr) 2005-01-19 2006-07-27 Biolipox Ab Indoles utiles dans le traitement de l'inflammation
CA2594773A1 (fr) 2005-01-19 2006-07-27 Biolipox Ab Indoles utiles dans le traitement de l'inflammation
ITMI20051523A1 (it) 2005-08-03 2007-02-04 Acraf Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
WO2007042816A1 (fr) 2005-10-12 2007-04-19 Biolipox Ab Benzoxazoles convenant pour le traitement d'une inflammation
EP1934173A1 (fr) 2005-10-13 2008-06-25 Biolipox AB Naphthalene-disulfonamides convenant pour le traitement d'une inflammation
EP1954134B1 (fr) 2005-11-23 2011-09-14 Merck Sharp & Dohme Corp. Procede de synthese d'un derive 2-phenyl-1h-phenantrho[9,10-d]imidazole
JP2009527508A (ja) 2006-02-24 2009-07-30 メルク フロスト カナダ リミテツド ２−（フェニル又は複素環）−１ｈ−フェナントロ［９，１０−ｄ］イミダゾール
WO2008084218A1 (fr) * 2007-01-12 2008-07-17 Boehringer Ingelheim International Gmbh Dérivés de benzazole pour le traitement d'inflammations

Also Published As

Publication number Publication date
JP2013525339A (ja) 2013-06-20
WO2011131975A1 (fr) 2011-10-27

Similar Documents

Publication Publication Date Title
GB201005589D0 (en) Novel compounds
GB201007203D0 (en) Novel compounds
EP2590647A4 (fr) Composés proneurogènes
GB201012686D0 (en) Novel compounds
GB201007791D0 (en) Novel compounds
GB201021314D0 (en) Novel compounds
GB201021310D0 (en) Novel compounds
GB201021311D0 (en) Novel compounds
GB201020909D0 (en) Novel compounds
GB201020622D0 (en) Novel compounds
GB201020607D0 (en) Novel compounds
GB201019576D0 (en) Novel compounds
GB201019547D0 (en) Novel compounds
GB201019480D0 (en) Novel compounds
GB201019575D0 (en) Novel compounds
GB201014230D0 (en) Novel compounds
GB201014232D0 (en) Novel compounds
GB201014231D0 (en) Novel compounds
GB201012924D0 (en) Novel compounds
GB201012922D0 (en) Novel compounds
GB201010509D0 (en) Novel compounds
GB201010514D0 (en) Novel compounds
GB201010506D0 (en) Novel compounds
GB201010508D0 (en) Novel compounds
GB201010511D0 (en) Novel compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: COVERGENCE PHARMACEUTICALS LIMITED

Free format text: FORMER OWNER: GLAXO GROUP LIMITED

AT Applications terminated before publication under section 16(1)